Furey Raymond J. 4

What Happened
Raymond J. Furey, EVP, General Counsel, Chief Compliance Officer and Corporate Secretary of Rigel Pharmaceuticals (RIGL), disposed of 3,546 shares on Feb 10, 2026 to satisfy a tax liability. The shares were recorded at $34.62 each, for a total value of approximately $122,763. This was a tax-withholding disposition (not an open-market sale).

Key Details

• Transaction date: 2026-02-10; Form 4 filed: 2026-02-12 (appears timely).
• Price per share: $34.62; shares disposed: 3,546; total value: ~$122,763.
• Transaction code: F — payment of exercise price or tax liability (shares surrendered/withheld).
• Shares owned after transaction: not specified in the provided filing.
• This was a withholding/disposition to cover taxes, not a market sale for cash proceeds to the insider.

Context
Code F transactions commonly reflect shares withheld or surrendered to satisfy tax withholding obligations after option exercises or restricted stock vesting. These are routine administrative actions and do not necessarily indicate a change in the insider’s view of the company. Purchases typically carry more interpretive weight for assessing insider sentiment.